State‐of‐the‐art 2023 on gene therapy for phenylketonuria
M Martinez, CO Harding, G Schwank… - Journal of inherited …, 2024 - Wiley Online Library
Phenylketonuria (PKU) or hyperphenylalaninemia is considered a paradigm for an inherited
(metabolic) liver defect and is, based on murine models that replicate all human pathology …
(metabolic) liver defect and is, based on murine models that replicate all human pathology …
[HTML][HTML] Development of an mRNA replacement therapy for phenylketonuria
CG Perez-Garcia, R Diaz-Trelles, JB Vega… - … Therapy-Nucleic Acids, 2022 - cell.com
Phenylketonuria (PKU) is an inborn error caused by deficiencies in phenylalanine (Phe)
metabolism. Mutations in the phenylalanine hydroxylase (PAH) gene are the main cause of …
metabolism. Mutations in the phenylalanine hydroxylase (PAH) gene are the main cause of …
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice
ML Cacicedo, C Weinl-Tenbruck, D Frank… - … in Bioengineering and …, 2022 - frontiersin.org
Phenylketonuria (PKU) is an inborn error of metabolism caused by a deficiency in functional
phenylalanine hydroxylase (PAH), resulting in accumulation of phenylalanine (Phe) in …
phenylalanine hydroxylase (PAH), resulting in accumulation of phenylalanine (Phe) in …
A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes
LP van Lieshout, M Rubin, K Costa-Grant, S Ota… - … Therapy Methods & …, 2023 - cell.com
Transient transfection of mammalian cells using plasmid DNA is a standard method to
produce adeno-associated virus (AAV) vectors allowing for flexible and scalable …
produce adeno-associated virus (AAV) vectors allowing for flexible and scalable …
Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria
Phenylketonuria (PKU) is a genetic deficiency of phenylalanine hydroxylase (PAH) in liver
resulting in blood phenylalanine (Phe) elevation and neurotoxicity. A pegylated …
resulting in blood phenylalanine (Phe) elevation and neurotoxicity. A pegylated …
Inborn errors of amino acid metabolism–from underlying pathophysiology to therapeutic advances
SG Ziegler, J Kim, JT Ehmsen… - Disease Models & …, 2023 - journals.biologists.com
Amino acids are organic molecules that serve as basic substrates for protein synthesis and
have additional key roles in a diverse array of cellular functions, including cell signaling …
have additional key roles in a diverse array of cellular functions, including cell signaling …
Liver directed adeno‐associated viral vectors to treat metabolic disease
MA Chuecos, WR Lagor - Journal of Inherited Metabolic …, 2024 - Wiley Online Library
The liver is the metabolic center of the body and an ideal target for gene therapy of inherited
metabolic disorders (IMDs). Adeno‐associated viral (AAV) vectors can deliver transgenes to …
metabolic disorders (IMDs). Adeno‐associated viral (AAV) vectors can deliver transgenes to …
Clinical, genetic, and experimental research of hyperphenylalaninemia
A Chen, Y Pan, J Chen - Frontiers in Genetics, 2023 - frontiersin.org
Hyperphenylalaninemia (HPA) is the most common amino acid metabolism defect in
humans. It is an autosomal-recessive disorder of the phenylalanine (Phe) metabolism, in …
humans. It is an autosomal-recessive disorder of the phenylalanine (Phe) metabolism, in …
DNA read count calibration for single-molecule, long-read sequencing
LMM Soares, T Hanscom, DE Selby, S Adjei… - Scientific Reports, 2022 - nature.com
There are many applications in which quantitative information about DNA mixtures with
different molecular lengths is important. Gene therapy vectors are much longer than can be …
different molecular lengths is important. Gene therapy vectors are much longer than can be …